Tuesday, April 07, 2009

Prescription Drug Services for Direct Medical Practice

"If you can buy [prescription drugs] in one market for $50 and sell it in another market for $100, why wouldn't [the initial price rise] to $95 to the second market? They still get a deal, but ... a number of middlemen along the way have made a profit. That's just economics 101. There's no obligation for anyone to sell it at a particular price. As long as [pharmaceuticals imported from abroad] come in below the market price in the U.S., then there is a 'savings,' but the savings might be trivial."

— Adam Fein, Ph.D., president of Pembroke Consulting, Inc., told AIS's DRUG BENEFIT NEWS. 

Interesting comments on prescription pricing... One benefit pediatricians can provide in a direct pediatrics service model and one that the Personal Pediatrics Platform includes is branded pharmaceuticals for use directly prescribing to the patient.  It's great to mix up amox in the home for a baby with an acute otitis media and give their first dose.  Parents love this as a service and it provides another cash revenue stream for the pediatrician.  

Let us know if we can help you create  a customized direct medical practice service line for your practice, or simply license our process for even greater cost savings and cash flow in the future for your practice.  

Natalie Hodge MD FAAP

No comments: